← TrialMatch
HomeTrials

Diagnostic Value of Confocal Laser Endomicroscopy (CelTouch) for Peripheral Lung Lesions

This study uses CelTouch to explore patients with lung lesions scheduled for lung biopsy. By comparing with preclinical CLE images and pathological images, CLE diagnostic criteria for benign and malignant lung lesions under the microscope will be established; the performance of CLE in diagnosing peripheral lung lesions

Condition(s)Peripheral Pulmonary Lesion
StatusRecruiting
Study typeObservational
SummaryThis study uses CelTouch to explore patients with lung lesions scheduled for lung biopsy. By comparing with preclinical CLE images and pathological images, CLE diagnostic criteria for benign and malignant lung lesions under the microscope will be established; the performance of CLE in diagnosing peripheral lung lesions will be validated through multicenter clinical research; and a CLE atlas for peripheral lung lesions will be constructed to establish a visual classification diagnostic system for peripheral lung lesions. (1) Comparative Study of In Vivo CLE Images and Pathological Images in the Diagnosis of Peripheral Lung Lesions 1. Collect CLE images and histopathological sections of clearly diagnosed peripheral lung lesions. 2. A diagnostic team composed of 1 bronchoscopy expert, 1 patho
Who can participateInclusion Criteria: 1. Aged ≥18 years, with lung lesions detected by chest CT and scheduled for lung biopsy; 2. Preoperative CT indicates the presence of a bronchus leading to the lesion to be biopsied; 3. Able to understand and willing to sign a written informed consent form. - Exclusion Criteria: 1. Those with contraindications to general anesthesia or bronchoscopy; 2. Patients with uncorrectable coagulation disorders; 3. Unable to discontinue therapeutic anticoagulants within an appropriate time interval before surgery; 4. Patients with severe liver or kidney dysfunction, cardiovascular and cerebrovascular diseases, mental illnesses, etc.; 5. Pregnant or lactating patients; 6. Those without a clear histological or clinical diagnosis; 7. Subjects deemed unsuitable by the investigator. -
Ages18 Years to 80 Years
SexAll
Lead sponsorGuangzhou Medical University
LocationsGuangzhou, Guangdong, China
Start date2025-05-31
NCT IDNCT07004946
Official listinghttps://clinicaltrials.gov/study/NCT07004946

🔍 Search all trials →